Rectal cancer stage 3 survival rate. Probleme actuale privind aplicarea protocolului de tratament în cancerul de rect Que es papiloma humano [Strategy and tactic in the treatment of local advanced rectal cancer]. Inoperable rectal tumour, no metastases: A radio-chemotherapy with a favourable response surgery B radio-chemotherapy with a non-favourable response chemotherapy Operable rectal tumour, with metastases: radical surgery of the tumour with resection of the hepatic or lung metastasis radio-chemotherapy radio-chemotherapy followed by surgical treatment.
Source: Acta Medica Transilvanica. In patients with colon cancer, the rate of survival is strongly correlated with the status of the lymph nodes.
Several authors report a lower survival rate when LN micrometastases colorectal cancer mortality rate detected. SLN have the greatest potential of developing metastases, and their evaluation is more cost-effective and more efficient.
Moreover, the intraoperative nodular mapping can enable the detection of aberrant lymphatic drainage pathways, which leads to a more extensive resection. Copyright of Acta Medica Transilvanica is the property of Acta Medica Transilvanica and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission.
Loco-regional advanced colorectal cancer: diagnostic and therapeutic features. Dec, Vol.
However, users may print, download, or email articles for individual use. This abstract may be abridged.
No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. Important User Information: Remote access to EBSCO's databases is permitted to patrons of subscribing institutions accessing from remote locations for personal, non-commercial use.
However, remote access to EBSCO's databases from non-subscribing institutions is not allowed if the purpose of the use is for commercial gain through cost reduction colorectal cancer mortality rate avoidance for a non-subscribing colorectal cancer mortality rate.